Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells

  • Authors:
    • Xiang Zhang
    • Kebin Zheng
    • Chunhui Li
    • Yonghui Zhao
    • Heyang Li
    • Xuguang Liu
    • Yinbo Long
    • Junchao Yao
  • View Affiliations

  • Published online on: March 23, 2017     https://doi.org/10.3892/or.2017.5522
  • Pages: 2847-2856
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Epithelial-mesenchymal transition (EMT) is a pivotal event in tumor progression during which cancer cells undergo dramatic changes acquiring highly invasive properties. In this study, we found that nobiletin, a polymethoxylated flavone, suppressed migration and invasion in both U87 and U251 glioma cells. Expression of epithelial markers (E-cadherin and occludin) was upregulated; mesenchymal markers (N-cadherin, fibronectin) and the transcriptional factor Slug were downregulated after nobiletin treatment. Transforming growth factor β (TGF-β) was applied to stimulate EMT and the results showed that nobiletin not only influenced basal level cell migration but also prevented TGF-β-triggered migration and EMT, with the AKT/GSK3β/β-catenin signaling pathway greatly involved. Furthermore, nobiletin remarkably diminished TGF-β-induced β-catenin nuclear translocation and the binding to the Slug promoter. It is worth noting that nobiletin almost blocked invasion in Slug-expressing U87 and U251 cells, and only exhibiting faint effect on non-Slug-expressing U343 glioma cells. Reinforced Slug expression in U343 cells by transfecting Slug plasmid was significantly attenuated by nobiletin, demonstrating the essential role of Slug in the anti-metastasis effect of nobiletin. Nobiletin repressed tumor growth in vivo and abrogated EMT in nude mice bearing U87-Luc xenografts, as demonstrated by Xenogen IVIS imaging and immunohistochemistry assay. Our findings suggested that nobiletin might have a great potential for treating glioblastoma.
View Figures
View References

Related Articles

Journal Cover

May-2017
Volume 37 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X, Zheng K, Li C, Zhao Y, Li H, Liu X, Long Y and Yao J: Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells. Oncol Rep 37: 2847-2856, 2017
APA
Zhang, X., Zheng, K., Li, C., Zhao, Y., Li, H., Liu, X. ... Yao, J. (2017). Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells. Oncology Reports, 37, 2847-2856. https://doi.org/10.3892/or.2017.5522
MLA
Zhang, X., Zheng, K., Li, C., Zhao, Y., Li, H., Liu, X., Long, Y., Yao, J."Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells". Oncology Reports 37.5 (2017): 2847-2856.
Chicago
Zhang, X., Zheng, K., Li, C., Zhao, Y., Li, H., Liu, X., Long, Y., Yao, J."Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells". Oncology Reports 37, no. 5 (2017): 2847-2856. https://doi.org/10.3892/or.2017.5522